Canada/US: bioterrorism highlights double standard for access to medicines.
In September 2001, shortly after terrorist attacks in the United States, the issue of bioterrorism--and specifically fear about reported cases of anthrax in the US--led the Canadian Minister of Health to be concerned about the available stocks of the drug ciprofloxacin to treat this disease.
Richard
R
Elliott
D000890:Anti-Infective Agents / Q000600:supply & distribution*; D023482:Bioterrorism; D002170:Canada; D002939:Ciprofloxacin / Q000600:supply & distribution*; D006297:Health Services Accessibility; D014481:United States
D000890:Anti-Infective Agents; D002939:Ciprofloxacin